Anonymous
Guest
Anonymous
Guest
This will be a huge gauge to see how much of a disaster bringing the Mallinckrodt office based reps into OFIRMEV sales. An old mentor of mine called me this past week. I consider this person to be highly intelligent and knows the industry inside out. He is a very successful RBD at another company (which many here probably know) but has been following the evolution of Ofirmev. After saying "hello," he offered me a job (which I'm not interested as I don't want to get back in that specific area of medicine) and said if I didn't take the job to start immediately looking. He believed this would be an epic fail and we most likely will lose a lot of valuable credibility especially with the surgeons.
If they had done any marketing research whatsoever, they would find that over 95% of all physicians pulled do not want to interact and spend time with more than one representative about the same drug (this coming from RBD above). Moreover, most Ofirmev conversations wrap with discussing hospital protocol and specific procedures, which these office based reps know nothing about. The first sign of ignorance loses all credibility for the drug, the company, and even us. Thought you were competing enough time with the Exporel and Cadolor reps etc.? Now it will be much worse. A MALLINCKRODT rep will be affecting your selling time while at the same time turning an Ofirmev call into a typical drug push call instead of the hospital partnership/relationship we created to improve their order sets and protocols we all helped to develop.
If they had done any marketing research whatsoever, they would find that over 95% of all physicians pulled do not want to interact and spend time with more than one representative about the same drug (this coming from RBD above). Moreover, most Ofirmev conversations wrap with discussing hospital protocol and specific procedures, which these office based reps know nothing about. The first sign of ignorance loses all credibility for the drug, the company, and even us. Thought you were competing enough time with the Exporel and Cadolor reps etc.? Now it will be much worse. A MALLINCKRODT rep will be affecting your selling time while at the same time turning an Ofirmev call into a typical drug push call instead of the hospital partnership/relationship we created to improve their order sets and protocols we all helped to develop.